Clinical Trials Directory

Trials / Completed

CompletedNCT06148259

SGLT Inhibitors Versus DDP4 Inhibitors and Prostate in Patient With Diabetes

Comparison of Two Novel Anti Diabetes Medications Classes as Regard Prostate Symptoms in Patient With Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
57 (actual)
Sponsor
Kasr El Aini Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study aims to compare the effect of two different classes of anti- diabetes medications on prostate volume and symptoms in elderly patients with diabetes mellitus

Detailed description

The study aims to compare the effect of two different classes of anti- diabetes medications on prostate volume and symptoms in elderly patients with diabetes mellitus The study compares sodium glucose cotransporter 2 inhibitors to Dipeptidyl peptidase 4 inhibitors in elderly patients with type 2 diabetes mellitus

Conditions

Interventions

TypeNameDescription
OTHERInternational prostate symptom scoreQuestionnaire of 8 questions to be administered to all patients about prostate symptoms
DIAGNOSTIC_TESTAssessment of prostate volumeMeasurements using ultrasound
OTHERPittsburgh sleep quality IndexQuestionnaire to assess quality of sleep
DIAGNOSTIC_TESTGlycated hemoglobinMeasures control of diabetes

Timeline

Start date
2021-03-12
Primary completion
2022-09-13
Completion
2022-09-13
First posted
2023-11-28
Last updated
2023-11-28

Locations

2 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06148259. Inclusion in this directory is not an endorsement.

SGLT Inhibitors Versus DDP4 Inhibitors and Prostate in Patient With Diabetes (NCT06148259) · Clinical Trials Directory